Omada Health Stock $4.14

Forge Price BeaconForge Price 1 updated October 25, 2024

omadahealth.comHealthcare / Digital HealthFounded: 2011Funding to Date: $459.88MM

Omada Health, founded in 2011, is a digital health company that aims to help individuals achieve their wellness objectives by fostering long-lasting lifestyle modifications. The company offers a comprehensive digital care program, which provides personalized support and guidance seeking to empower users in taking charge of their health and well-being. Omada Health is headquartered in San Francisco, California.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for Omada Health, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Private Market Pricing DetailsValuation & Financings

Omada Health Stock Price

3M
6M
1Y
MAX
Forge Price 1
Date
10/25/2024
Price per Share
$4.14
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Omada Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
02/23/2022 Series E $192MM $xx.xx $1.02B Fidelity, aMoon, Perceptive Advisors, Wellington Management, Civilization Ventures
Price per Share
$xx.xx
Shares Outstanding
32,025,620
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Fidelity, aMoon, Perceptive Advisors, Wellington Management, Civilization Ventures
03/16/2021 Series D-1 $27MM $xx.xx $780.77MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
4,503,601
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
05/19/2020 Series D $112.47MM $xx.xx $612.85MM Perceptive Advisors, Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi-Genzyme Bioventures, US Venture Partners, Wellington Management
Price per Share
$xx.xx
Shares Outstanding
22,330,212
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Perceptive Advisors, Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi-Genzyme Bioventures, US Venture Partners, Wellington Management
05/10/2017 Series C-1 $49.99MM $xx.xx $320.25MM Cigna, Civilization Ventures, Sanofi Genzyme BioVentures, U.S. Venture Partners, Andreessen Horowitz, Norwest Venture Partners, Humana, Kaiser Permanente Ventures, Providence Ventures, dRx Capital, GE Ventures
Price per Share
$xx.xx
Shares Outstanding
13,357,797
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Cigna, Civilization Ventures, Sanofi Genzyme BioVentures, U.S. Venture Partners, Andreessen Horowitz, Norwest Venture Partners, Humana, Kaiser Permanente Ventures, Providence Ventures, dRx Capital, GE Ventures
10/01/2015 Series C $48.67MM $xx.xx $216.43MM Norwest Venture Partners, Providence Ventures, Humana Ventures, US Venture Partners, Rock Health, Andreessen Horowitz, Designer Fund, GE Ventures, IDEO Futures, dRx Capital
Price per Share
$xx.xx
Shares Outstanding
15,385,707
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Norwest Venture Partners, Providence Ventures, Humana Ventures, US Venture Partners, Rock Health, Andreessen Horowitz, Designer Fund, GE Ventures, IDEO Futures, dRx Capital
04/09/2014 Series B $23.33MM $xx.xx $60.57MM Andreessen Horowitz, Kaiser Permanente Ventures, U.S. Venture Partners, The Vertical Group
Price per Share
$xx.xx
Shares Outstanding
19,724,378
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Kaiser Permanente Ventures, U.S. Venture Partners, The Vertical Group
03/21/2013 Series A $6.43MM $xx.xx $16.11MM U.S. Venture Partners, The Vertical Group, Founder Collective, New Enterprise Associates, TriplePoint Capital, Kapor Capital, HealthTech Capital
Price per Share
$xx.xx
Shares Outstanding
12,027,426
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
U.S. Venture Partners, The Vertical Group, Founder Collective, New Enterprise Associates, TriplePoint Capital, Kapor Capital, HealthTech Capital

Omada Health investors also invested in these private companies

Civilization Ventures
Humana Ventures
The Vertical Group
Providence Ventures
Healthtech Capital
Ideo Futures
Sanofi-Genzyme Bioventures
Drx Capital

Leadership & Board

Leadership

Steve Cook
Chief Financial Officer
Sunil Kayiti
Chief Technology Officer
Sean Duffy
Co-Founder & Chief Executive Officer
Wei-Li Shao
President
Carolyn Jasik, MD
Chief Medical Officer
Randhir Vieira
Chief Product Officer
Adrian James
Co-Founder

Board

Casper de Clercq
Norwest Venture Partners
Jonathan Root, M.D.
USVP

Omada Health stock FAQs

plusminus

Can you buy Omada Health stock?

As Omada Health is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Omada Health, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy Omada Health stock?

To invest in a private company like Omada Health through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Omada Health stock?

Yes, you may sell the Omada Health stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Omada Health stock?

If you hold private company shares of Omada Health – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Omada Health on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is Omada Health a public company?

No, Omada Health is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Omada Health’s stock price?

Omada Health is a private company, meaning it does’t have a publicly traded stock price. However, as of 10/25/2024 the Omada Health Forge Price is $4.14 per share. The Forge Price is a derived price calculated for private companies like Omada Health to provide insights into their current valuation. Learn more about Forge Price.
plusminus

What is Omada Health’s stock ticker symbol?

Omada Health does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Omada Health’s news and media highlights

Omada's new program provides coaching, peer support and educational materials to patients struggling with chronic obesity and taking GLP-1s. The company chose not to prescribe the weight loss drugs itself.
Omada Health, a virtual, integrated chronic care healthcare provider, and Castell, Intermountain Healthcare’s value-based care subsidiary, have entered into a partnership that expands the access of Omada’s Diabetes Prevention Program and Diabetes Program to patients and caregivers receiving care from Intermountain Healthcare’s primary care providers within its Utah Medical Group.
Many sectors are down during the pandemic. Online health is not one of them.
Omada Health, a digital care platform, received an investment from Intermountain Ventures, the strategic investment arm of Intermountain Healthcare
Updated on: Oct 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.